Goldline Pharmaceutical Fundamental Analysis
29.60.60 (2.07%)
Last updated on 19 Nov, 2026 | 16:00 IST
Free Demat with Zero AMC*
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Goldline Pharmaceutical Score Card
Price
Expensive
Growth
Average
Quality
Good
Management
Good
On its scorecard, Goldline Pharmaceutical reflects: Price – Expensive, Growth – Average, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.
Goldline Pharmaceutical Associated Pages
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in GLPL
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC